GENEDX HOLDINGS CORP

Genedx (WGS) plunged 16.4% on Nov. 26, falling well below its 200‑day SMA. Explore the sharp decline, market context, and future outlook for this AI‑driven health‑intel stock.

Genedx’s 4.2% rally highlights the volatility of an AI‑driven genomic analytics firm—investors weigh tech promise against fragile valuation, regulatory hurdles, and fierce competition.